Table of Content

1. Executive Summary
   1.1. Global Inflammatory Bowel Disease Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 – 2031, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
       2.3.3. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors – Relevance and Impact
3. Value Added Insights
   3.1. Technology Assessment
   3.2. Regulatory Landscape
   3.3. Value Chain Analysis
   3.4. Key Deals and Mergers
   3.5. PESTLE Analysis
   3.6. Porter’s Five Force Analysis
   3.7. Regional Prices and Disease Type Preferences
4. Global Inflammatory Bowel Disease Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Mn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
       4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023–2031
   4.3. Global Inflammatory Bowel Disease Market Outlook: Disease Type
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Mn) Analysis, By Disease Type, 2018 – 2022
       4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Type, 2023 – 2031
           4.3.3.1. Crohn's Disease
           4.3.3.2. Ulcerative Colitis
   4.4. Market Attractiveness Analysis: Disease Type
   4.5. Global Inflammatory Bowel Disease Market Outlook: Drug Class
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2018 – 2022
       4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 – 2031
           4.5.3.1. Aminosalicylates
           4.5.3.2. Corticosteroids
           4.5.3.3. Immunomodulators
           4.5.3.4. Others
   4.6. Market Attractiveness Analysis: Drug Class
   4.7. Global Inflammatory Bowel Disease Market Outlook: Distribution Channel
       4.7.1. Introduction / Key Findings
       4.7.2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2018 – 2022
       4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 – 2031
           4.7.3.1. Hospital Pharmacies
           4.7.3.2. Retail Pharmacies
           4.7.3.3. E-Commerce Platforms
           4.7.3.4. Others
   4.8. Market Attractiveness Analysis: Distribution Channel
5. Global Inflammatory Bowel Disease Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 – 2022
   5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 – 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Inflammatory Bowel Disease Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   6.1. Key Highlights
   6.2. Pricing Analysis
   6.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
       6.3.1. By Country
       6.3.2. By Disease Type
       6.3.3. By Drug Class
       6.3.4. By Distribution Channel
   6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
       6.4.1. U.S.
       6.4.2. Canada
   6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Type, 2023 – 2031
       6.5.1. Crohn's Disease
       6.5.2. Ulcerative Colitis
   6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 – 2031
       6.6.1. Aminosalicylates
       6.6.2. Corticosteroids
       6.6.3. Immunomodulators
       6.6.4. Others
   6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 – 2031
       6.7.1. Hospital Pharmacies
       6.7.2. Retail Pharmacies
       6.7.3. E-Commerce Platforms
       6.7.4. Others
   6.8. Market Attractiveness Analysis
7. Europe Inflammatory Bowel Disease Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   7.1. Key Highlights
   7.2. Pricing Analysis
   7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
       7.3.1. By Country
       7.3.2. By Disease Type
       7.3.3. By Drug Class
       7.3.4. By Distribution Channel
   7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
       7.4.1. Germany
       7.4.2. France
       7.4.3. U.K.
       7.4.4. Italy
       7.4.5. Spain
       7.4.6. Russia
       7.4.7. Türkiye
       7.4.8. Rest of Europe
   7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Type, 2023 – 2031
       7.5.1. Crohn's Disease
       7.5.2. Ulcerative Colitis
   7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 – 2031
       7.6.1. Aminosalicylates
       7.6.2. Corticosteroids
       7.6.3. Immunomodulators
       7.6.4. Others
   7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 – 2031
       7.7.1. Hospital Pharmacies
       7.7.2. Retail Pharmacies
       7.7.3. E-Commerce Platforms
       7.7.4. Others
   7.8. Market Attractiveness Analysis
8. East Asia Inflammatory Bowel Disease Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   8.1. Key Highlights
   8.2. Pricing Analysis
   8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
       8.3.1. By Country
       8.3.2. By Disease Type
       8.3.3. By Drug Class
       8.3.4. By Distribution Channel
   8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
       8.4.1. China
       8.4.2. Japan
       8.4.3. South Korea
   8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Type, 2023 – 2031
       8.5.1. Crohn's Disease
       8.5.2. Ulcerative Colitis
   8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 – 2031
       8.6.1. Aminosalicylates
       8.6.2. Corticosteroids
       8.6.3. Immunomodulators
       8.6.4. Others
   8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 – 2031
       8.7.1. Hospital Pharmacies
       8.7.2. Retail Pharmacies
       8.7.3. E-Commerce Platforms
       8.7.4. Others
   8.8. Market Attractiveness Analysis
9. South Asia & Oceania Inflammatory Bowel Disease Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   9.1. Key Highlights
   9.2. Pricing Analysis
   9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
       9.3.1. By Country
       9.3.2. By Disease Type
       9.3.3. By Drug Class
       9.3.4. By Distribution Channel
   9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
       9.4.1. India
       9.4.2. Southeast Asia
       9.4.3. ANZ
       9.4.4. Rest of South Asia & Oceania
   9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Type, 2023 – 2031
       9.5.1. Crohn's Disease
       9.5.2. Ulcerative Colitis
   9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 – 2031
       9.6.1. Aminosalicylates
       9.6.2. Corticosteroids
       9.6.3. Immunomodulators
       9.6.4. Others
   9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 – 2031
       9.7.1. Hospital Pharmacies
       9.7.2. Retail Pharmacies
       9.7.3. E-Commerce Platforms
       9.7.4. Others
   9.8. Market Attractiveness Analysis
10. Latin America Inflammatory Bowel Disease Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   10.1. Key Highlights
   10.2. Pricing Analysis
   10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
       10.3.1. By Country
       10.3.2. By Disease Type
       10.3.3. By Drug Class
       10.3.4. By Distribution Channel
   10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
       10.4.1. Brazil
       10.4.2. Mexico
       10.4.3. Rest of Latin America
   10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Type, 2023 – 2031
       10.5.1. Crohn's Disease
       10.5.2. Ulcerative Colitis
   10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 – 2031
       10.6.1. Aminosalicylates
       10.6.2. Corticosteroids
       10.6.3. Immunomodulators
       10.6.4. Others
   10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 – 2031
       10.7.1. Hospital Pharmacies
       10.7.2. Retail Pharmacies
       10.7.3. E-Commerce Platforms
       10.7.4. Others
   10.8. Market Attractiveness Analysis
11. Middle East & Africa Inflammatory Bowel Disease Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
   11.1. Key Highlights
   11.2. Pricing Analysis
   11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
       11.3.1. By Country
       11.3.2. By Disease Type
       11.3.3. By Drug Class
       11.3.4. By Distribution Channel
   11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Type, 2023 – 2031
       11.4.1. Crohn's Disease
       11.4.2. Ulcerative Colitis
   11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 – 2031
       11.5.1. Aminosalicylates
       11.5.2. Corticosteroids
       11.5.3. Immunomodulators
       11.5.4. Others
   11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 – 2031
       11.6.1. Hospital Pharmacies
       11.6.2. Retail Pharmacies
       11.6.3. E-Commerce Platforms
       11.6.4. Others
   11.7. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping by Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
       12.3.1. AbbVie Inc.
           12.3.1.1. Overview
           12.3.1.2. Segments and Disease Types
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Janssen Biotech, Inc.
       12.3.3. Pfizer Inc.
       12.3.4. Takeda Pharmaceutical Company Limited
       12.3.5. Ferring Pharmaceuticals
       12.3.6. Amgen Inc.
       12.3.7. Eli Lilly and Company
       12.3.8. Novartis AG
       12.3.9. Bristol-Myers Squibb
       12.3.10. Johnson & Johnson
       12.3.11. Merck & Co., Inc.
       12.3.12. GlaxoSmithKline plc
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations